Latest radiation therapy Stories

Novel approach using Listeria bacteria shows promise against a deadly disease BRONX, N.Y., April 24, 2013 /PRNewswire-USNewswire/-- Researchers at Albert Einstein College of Medicine of Yeshiva University have developed a therapy for pancreatic cancer that uses Listeria bacteria to selectively infect tumor cells and deliver radioisotopes into them. The experimental treatment dramatically decreased the number of metastases (cancers that have spread to other parts of the body) in a...

LONDON, ON, April 24, 2013 /PRNewswire/ - A world first procedure performed at London Health Sciences Center (LHSC) and facilitated by research at Lawson Health Research Institute (Lawson) provides a new minimally invasive treatment option for patients with localized prostate cancer. The treatment - transurethral magnetic resonance (MR) guided ultrasound ablation for prostate cancer - utilizes a new ablation device that uses thermal ultrasound therapy with real-time MR image...

GLENWOOD, Ill., April 23, 2013 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, will release financial results for the fiscal second quarter 2013 after the market close on Monday, May 6, 2013. The Company will host a conference call for investors on Tuesday, May 7, 2013, at 9:00 a.m. Central Time (10 a.m. Eastern...

Voices Against Brain Cancer (VABC), the organization dedicated to brain cancer research and advocacy, responds to an article published on biosciencetechnology.com that examines a Phase 2 clinical trial study focusing on a new brain cancer treatment. New York, NY (PRWEB) April 22, 2013 On April 22, Voices Against Brain Cancer (VABC), an organization dedicated to brain cancer research and advocacy, comments on an article published by Biosciencetechnology.com that discusses a new Phase 2...

Two large, landmark radiotherapy studies have shown that it is possible to treat cervical cancer effectively with high doses specifically adapted to each tumor, and with fewer serious side-effects to the surrounding normal organs. In two presentations today (Saturday) and tomorrow (Sunday) researchers will tell the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO) that image-guided brachytherapy is able to deliver very high doses, which prevent the tumor from growing...

Researchers have shown for the first time that it is possible to reduce the distressing symptoms of dry mouth in patients treated with radiotherapy for head and neck cancers if the radiation dose to a salivary gland (called the submandibular gland) on the opposite side to the tumor is kept to the minimum. The largest study yet to show a correlation between radiation doses to the submandibular glands and their output of saliva was presented today (Saturday) at the 2nd Forum of the European...

Mathematical prediction models are better than doctors at predicting the outcomes and responses of lung cancer patients to treatment, according to new research presented today (Saturday) at the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO). These differences apply even after the doctor has seen the patient, which can provide extra information, and knows what the treatment plan and radiation dose will be. "The number of treatment options available for lung...

More than 800 oncology professionals at European Society for Radiotherapy and Oncology forum hear of pioneering treatment delivery, motion management and tumor-tracking technologies for tackling the growing lung cancer burden GENEVA, April 22, 2013 /PRNewswire/ -- Cancer experts have reported future trends and progress in radiotherapy treatments for lung cancer using motion management and tumor-tracking technologies from Varian Medical Systems (NYSE: VAR). Speakers at Varian's...

GENEVA, April 22, 2013 /PRNewswire/ -- Better outcomes can be achieved for prostate cancer patients using brachytherapy, a highly targeted form of radiotherapy, compared to surgery - this is the finding of a new study conducted by PANAXEA, The University of Twente, Netherlands.(1) The study, which will be presented at the European Society for Radiotherapy and Oncology (ESTRO) 19-23 April 2013, Geneva, Switzerland used the latest cost effectiveness model to look at relevant recent...

redOrbit Staff & Wire Reports - Your Universe Online Damage to the heart and lungs caused by treating tumors in a person’s chest area can be limited through the use of drug typically used to treat cardiovascular disease, a team of Dutch researchers claim in a new study. Dr. Sonja Van der Veen of the University Medical Centre, Groningen (UMCG), and colleagues intended to find out whether or not angiotensin-converting enzyme (ACE) inhibitors could help prevent a condition known as...